期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effects of Neuregulins on Invasion and Metastasis of Non-overexpression ErbB2 Breast Cancer Cells
1
作者 Ya-mei Zhang Ting-ting Zhao Hua-yu Deng 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2009年第2期115-121,共7页
Objective: To explore the effects of neuregulins on ErbB2 receptor signal transduction pathway activation, and invasion and metastasis of non-overexpression ErbB2 breast cancer cell MDA-MB-231. Methods: The express... Objective: To explore the effects of neuregulins on ErbB2 receptor signal transduction pathway activation, and invasion and metastasis of non-overexpression ErbB2 breast cancer cell MDA-MB-231. Methods: The expressions of neuregulin were detected by immunocytochemistry and Western blot. MDA-MB-231 cells were treated with ErbB2 kinase inhibitor AG825. Proliferations were measured with MTT assay. Invasion and metastasis of MDA-ME-231 cells were evaluated with transwell chamber. The enzyme activities of MMP-2 and MMP-9 were detected by gelatin zymography. The expressions of MMP-2 and HIF-1α were detected by Western blot. Results: MDA-MB-231 cells expressed a relatively higher level of neuregulin. In Western blot, the positive reaction band was found at 44KD which coincides with the molecular weight of NRG. When MDA-MB-231 cells were treated with AG825, the proliferation was inhibited in a time-dose-dependent manner (P〈0.01), invasion and metastasis were also depressed (P〈0.05). The enzyme activities of MMP-2 and MMP-9 were lower (P〈0.05). The expression levels of MMP-2 and HIF-lct were decreased (P〈0.05). Conclusion: Our study indicates that neuregulins are synthesized in MDA-MB-231 cells as transmembrane proteins, neuregulins could activate ErbB2 receptor signal transduction pathway by autocrine or paracrine secretion, and induce invasion and metastasis of MDA-MB-231 cells. 展开更多
关键词 non-overexpression erbb2 breast cancer NEUREGULINS Invasion Metastasis
下载PDF
ErbB2受体抑制剂AG825对ErbB2非过表达乳腺癌细胞增殖的作用及意义 被引量:1
2
作者 赵婷婷 邓华瑜 +2 位作者 赵敬 杜佳 陈黎 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第12期1646-1650,共5页
目的:探讨在ErbB2非过表达乳腺癌细胞中是否存在NRGs/ErbB2这种配体作用方式的信号通路活化,进而研究神经调节因子(Neuregulins’NRGs)对ErbB2受体信号转导活化和细胞增殖生长的作用。方法:以ErbB2非过表达乳腺癌细胞MDA-MB-231和MCF-7... 目的:探讨在ErbB2非过表达乳腺癌细胞中是否存在NRGs/ErbB2这种配体作用方式的信号通路活化,进而研究神经调节因子(Neuregulins’NRGs)对ErbB2受体信号转导活化和细胞增殖生长的作用。方法:以ErbB2非过表达乳腺癌细胞MDA-MB-231和MCF-7为研究对象,台盼蓝拒染法检测细胞生长曲线;免疫细胞化学法和Western blot法检测细胞中NRG的表达。应用ErbB2受体功能抑制剂AG825处理两株细胞,MTT法检测比较两株细胞的增殖抑制作用,求出AG825作用MDA-MB-231细胞48h的IC50。40μmol/LAG825处理MDA-MB-231细胞48h,流式细胞术检测细胞周期和细胞凋亡。结果:与MCF-7细胞比较,MDA-MB-231细胞具有较强的增殖生长能力。NRG在MDA-MB-231细胞内呈显著表达,MCF-7细胞中无NRG的表达。Western blot实验检测MDA-MB-231细胞可见分子量44kD的NRG抗体阳性反应条带。应用ErbB2受体功能抑制剂AG825后,MDA-MB-231细胞的增殖抑制作用明显,AG825作用MDA-MB-231细胞48h的IC50为56.59μmol/L。40μmol/LAG825处理MDA-MB-231细胞48h后,细胞周期阻滞在G0/G1期(P<0.05);细胞凋亡增加(P<0.01)。结论:ErbB2非过表达乳腺癌细胞MDA-MB-231可能通过NRGs自分泌或旁分泌作用方式使ErbB2受体信号转导处于激活状态,这与其高增殖、低凋亡恶性行为有关。 展开更多
关键词 erbb2非过表达乳腺癌细胞 AG825 神经调节因子 增殖
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部